Marcel Maier

4.3k total citations
19 papers, 976 citations indexed

About

Marcel Maier is a scholar working on Physiology, Molecular Biology and Neurology. According to data from OpenAlex, Marcel Maier has authored 19 papers receiving a total of 976 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 7 papers in Molecular Biology and 7 papers in Neurology. Recurrent topics in Marcel Maier's work include Alzheimer's disease research and treatments (9 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers) and Computational Drug Discovery Methods (4 papers). Marcel Maier is often cited by papers focused on Alzheimer's disease research and treatments (9 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers) and Computational Drug Discovery Methods (4 papers). Marcel Maier collaborates with scholars based in United States, Switzerland and Germany. Marcel Maier's co-authors include Timothy J. Seabrook, Cynthia A. Lemere, Liying Jiang, Ying Peng, Michael C. Carroll, Ueli Suter, Philipp Berger, Christopher Janus, Noel D. Lazo and Pritam Das and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and Scientific Reports.

In The Last Decade

Marcel Maier

19 papers receiving 958 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcel Maier United States 15 561 490 267 170 136 19 976
Mary Lou Previti United States 18 930 1.7× 591 1.2× 409 1.5× 236 1.4× 82 0.6× 27 1.5k
Karolien Bettens Belgium 18 839 1.5× 316 0.6× 616 2.3× 189 1.1× 148 1.1× 24 1.4k
Ilie‐Cosmin Stancu Belgium 14 992 1.8× 511 1.0× 696 2.6× 293 1.7× 101 0.7× 17 1.5k
Eva Czirr United States 14 635 1.1× 425 0.9× 391 1.5× 149 0.9× 149 1.1× 21 1.2k
Mickaël Audrain France 14 461 0.8× 380 0.8× 432 1.6× 175 1.0× 151 1.1× 28 1.1k
Christophe Verbeeck United States 9 633 1.1× 753 1.5× 267 1.0× 148 0.9× 321 2.4× 9 1.2k
Jennifer Rodriguez-Rivera United States 8 490 0.9× 455 0.9× 376 1.4× 226 1.3× 133 1.0× 8 1.0k
Patrick Wunderlich Germany 10 428 0.8× 330 0.7× 356 1.3× 97 0.6× 180 1.3× 11 891
Lu-Lin Jiang United States 12 584 1.0× 814 1.7× 319 1.2× 160 0.9× 381 2.8× 13 1.3k
Monika Žilková Slovakia 12 542 1.0× 300 0.6× 236 0.9× 182 1.1× 37 0.3× 19 732

Countries citing papers authored by Marcel Maier

Since Specialization
Citations

This map shows the geographic impact of Marcel Maier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcel Maier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcel Maier more than expected).

Fields of papers citing papers by Marcel Maier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcel Maier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcel Maier. The network helps show where Marcel Maier may publish in the future.

Co-authorship network of co-authors of Marcel Maier

This figure shows the co-authorship network connecting the top 25 collaborators of Marcel Maier. A scholar is included among the top collaborators of Marcel Maier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcel Maier. Marcel Maier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Rousseau, Jacques, Marcel Maier, Samia Aït‐Mohand, et al.. (2024). Antibody-Based PET Imaging of Misfolded Superoxide Dismutase 1 in an Amyotrophic Lateral Sclerosis Mouse Model. Journal of Nuclear Medicine. 66(1). 130–135. 1 indexed citations
2.
Kunz, Séverine, Sigrid Schnoegl, Gillian P. Bates, et al.. (2021). Small, Seeding-Competent Huntingtin Fibrils Are Prominent Aggregate Species in Brains of zQ175 Huntington’s Disease Knock-in Mice. Frontiers in Neuroscience. 15. 682172–682172. 9 indexed citations
3.
Hatzipetros, Theo, Joshua D. Kidd, Beth Levine, et al.. (2019). SOD1-positive aggregate accumulation in the CNS predicts slower disease progression and increased longevity in a mutant SOD1 mouse model of ALS. Scientific Reports. 9(1). 6724–6724. 50 indexed citations
4.
Maier, Marcel, Tobias Welt, Fabio Montrasio, et al.. (2018). A human-derived antibody targets misfolded SOD1 and ameliorates motor symptoms in mouse models of amyotrophic lateral sclerosis. Science Translational Medicine. 10(470). 58 indexed citations
5.
McAfoose, Jordan, Luka Kulic, Tobias Welt, et al.. (2014). Amyloid-β Peptide-specific DARPins as a Novel Class of Potential Therapeutics for Alzheimer Disease. Journal of Biological Chemistry. 289(39). 27080–27089. 14 indexed citations
6.
Dunstan, Robert W., Thierry Bussière, Marcel Maier, et al.. (2011). P2‐449: Molecular characterization and preclinical efficacy. Alzheimer s & Dementia. 7(4S_Part_13). 5 indexed citations
7.
Dunstan, Robert W., Thierry Bussière, Marcel Maier, et al.. (2011). P4‐006: The role of brain macrophages on the clearance of amyloid plaques following the treatment of Tc2576 with BIIB037. Alzheimer s & Dementia. 7(4S_Part_20). 1 indexed citations
8.
9.
Lemere, Cynthia A., Marcel Maier, Ying Peng, Liying Jiang, & Timothy J. Seabrook. (2007). Novel Aβ Immunogens: Is Shorter Better?. Current Alzheimer Research. 4(4). 427–436. 23 indexed citations
10.
Lemere, Cynthia A., Marcel Maier, Liying Jiang, Ying Peng, & Timothy J. Seabrook. (2006). Amyloid-Beta Immunotherapy for the Prevention and Treatment of Alzheimer Disease: Lessons from Mice, Monkeys, and Humans. Rejuvenation Research. 9(1). 77–84. 55 indexed citations
11.
Seabrook, Timothy J., Liying Jiang, Marcel Maier, & Cynthia A. Lemere. (2006). Minocycline affects microglia activation, Aβ deposition, and behavior in APP‐tg mice. Glia. 53(7). 776–782. 181 indexed citations
12.
Seabrook, Timothy J., Liying Jiang, E. T. C. Spooner, et al.. (2006). Dendrimeric Aβ1–15 is an effective immunogen in wildtype and APP-tg mice. Neurobiology of Aging. 28(6). 813–823. 48 indexed citations
13.
Maier, Marcel, Timothy J. Seabrook, Noel D. Lazo, et al.. (2006). Short Amyloid-β (Aβ) Immunogens Reduce Cerebral Aβ Load and Learning Deficits in an Alzheimer's Disease Mouse Model in the Absence of an Aβ-Specific Cellular Immune Response. Journal of Neuroscience. 26(18). 4717–4728. 114 indexed citations
14.
Maier, Marcel, Timothy J. Seabrook, & Cynthia A. Lemere. (2005). Developing Novel Immunogens for an Effective, Safe Alzheimer’s Disease Vaccine. Neurodegenerative Diseases. 2(5). 267–272. 16 indexed citations
15.
16.
Maier, Marcel, François Castagner, Philipp Berger, & Ueli Suter. (2003). Distinct elements of the peripheral myelin protein 22 (PMP22) promoter regulate expression in Schwann cells and sensory neurons. Molecular and Cellular Neuroscience. 24(3). 803–817. 31 indexed citations
17.
Maier, Marcel, Philipp Berger, Klaus‐Armin Nave, & Ueli Suter. (2002). Identification of the Regulatory Region of the Peripheral Myelin Protein 22 (PMP22) Gene That Directs Temporal and Spatial Expression in Development and Regeneration of Peripheral Nerves. Molecular and Cellular Neuroscience. 20(1). 93–109. 24 indexed citations
18.
Maier, Marcel, Philipp Berger, & Ueli Suter. (2002). Understanding Schwann cell–neurone interactions: the key to Charcot–Marie–Tooth disease?*. Journal of Anatomy. 200(4). 357–366. 21 indexed citations
19.
Stengelin, Siegfried, Wolfgang Becker, Marcel Maier, et al.. (1996). The Rabbit Ileal Lipid‐Binding Protein Gene Cloning and Functional Expression of the Recombinant Protein. European Journal of Biochemistry. 239(3). 887–896. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mary Lou Previti Breakdown of academic impact, for papers by Karolien Bettens Breakdown of academic impact, for papers by Ilie‐Cosmin Stancu Breakdown of academic impact, for papers by Eva Czirr Breakdown of academic impact, for papers by Mickaël Audrain Breakdown of academic impact, for papers by Christophe Verbeeck Breakdown of academic impact, for papers by Jennifer Rodriguez-Rivera Breakdown of academic impact, for papers by Patrick Wunderlich Breakdown of academic impact, for papers by Lu-Lin Jiang Breakdown of academic impact, for papers by Monika Žilková
Rankless by CCL
2026